SIMCOM message testing for effective healthcare communication

Effective communication with consumers has never been more critical. With an overwhelming volume of engagement and increasingly complex information to convey, cutting through the noise while staying compliant is a constant challenge. This is where SIMCOM™ comes in.

Developed by Adelphi Research, SIMCOM™ goes beyond traditional message testing, offering a cutting-edge approach to identifying, optimising and delivering impactful messaging. SIMCOM™ is the result of experimenting with a combination of advanced analytics and interactive methodologies; a framework that ensures your communication is clear, compelling and adaptable across various engagement opportunities.

Why SIMCOM™?

  • Identify High-Impact Messages – Pinpoint the messages that resonate most with HCPs.
  • Optimise Story Flow – Ensure your messaging is structured for maximum effectiveness.
  • Adapt to Market Changes – Make quick adjustments to align with evolving regulations and stakeholder needs.
  • Interactive and Engaging – Gamified message testing enhances data reliability and user experience.
  • Data-Driven Decisions – Advanced methodologies including TURF and MaxDiff deliver actionable insights.

Real-World Success

With a proven track record across multiple therapy areas, Adelphi Research has successful completed 200+ message testing studies globally. Clients from top pharma companies trust SIMCOM™ to refine their messaging and stand out in competitive markets.

“SIMCOM™ has proven to be a reliable methodology, providing clear and actionable insights by identifying messages that maximise impact, appeal broadly, and maintain a coherent story flow.” Global customer insights partner, top 10 pharma company.

Find out how SIMCOM™ can improve your messaging strategy. Download the full white paper to explore the methodology, key benefits and real-world applications.

If you would like someone to contact you about SIMCOM™, email [email protected] or contact one of your Adelphi team members.